Take the medication as soon as you remember. If your next scheduled dose is due within 12 hours, skip the missed dose and continue with your regular d···【Read More】
Update: 2026-03-24Source: Haiou HealthViews: 132
Indications for entrectinib:1. For the treatment of adult patients with ROS1-positive metastatic non-small cell lung cancer (NSCLC) confirmed by an FD···【Read More】
Update: 2026-03-24Source: Haiou HealthViews: 127
Patients should be aware of adverse reactions occurring during entrectinib use. If symptoms are severe, consult a doctor promptly for dosage adjustmen···【Read More】
Update: 2026-03-24Source: Haiou HealthViews: 130
Due to significant individual differences among cancer patients, including tumor molecular characteristics, physical function, and comorbidities, drug···【Read More】
Update: 2026-03-24Source: Haiou HealthViews: 129
Roche recently announced that the EC has conditionally approved the targeted anticancer drug Rozlytrek for the treatment of pediatric and adult patien···【Read More】
Update: 2026-03-24Source: Haiou HealthViews: 138
The European Commission (EC) has approved the targeted anticancer drug Rozlytrek (entrectinib) for the treatment of pediatric and adult patients aged ···【Read More】
Update: 2026-03-24Source: Haiou HealthViews: 112
On June 9, 2022, Foundation Medicine announced that the U.S. Food and Drug Administration (FDA) has approved FoundationOneCDx as a companion diagnosti···【Read More】
Update: 2026-03-24Source: Haiou HealthViews: 117
The U.S. Food and Drug Administration (FDA) announced on October 20 that it has granted accelerated approval to Rozlytrek (entrectinib) for the treatm···【Read More】
Update: 2026-03-24Source: Haiou HealthViews: 117
Crizotinib has a proven therapeutic effect on ALK-related diseases, effectively controlling tumor progression and improving patient clinical outcomes.···【Read More】
Update: 2026-03-24Source: Haiou HealthViews: 125
Crizotinib may cause side effects that do not require medical intervention and may gradually disappear as the body adapts to the drug during treatment···【Read More】
Update: 2026-03-24Source: Haiou HealthViews: 120
Crizotinib has different specific usages in adults and children for different indications. Users are advised to consult their doctor before using criz···【Read More】
Update: 2026-03-24Source: Haiou HealthViews: 128
The price of Pralsetinib varies depending on the region, medical insurance policies, and drug specifications. In the domestic market, the price is typ···【Read More】
Update: 2026-03-24Source: Haiou HealthViews: 103
The price of pralatinib varies depending on the strength, region, and purchase channel, typically ranging from 30,000 to 50,000 yuan per box. The spec···【Read More】
Update: 2026-03-24Source: Haiou HealthViews: 106
The price of pralatinib varies significantly depending on the drug version, strength, whether it is covered by medical insurance, and the purchase cha···【Read More】
Update: 2026-03-24Source: Haiou HealthViews: 111
Tepotinib use must strictly adhere to individualized treatment principles. The dosage and administration method should be determined by a specialist p···【Read More】
Update: 2026-03-23Source: Haiou HealthViews: 124
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos